Prehospital management of acute ST-elevation myocardial infarction: A time for reappraisal in North America

American Heart Journal

Volumn 145, Issue 1, 2003, Pages 1-8

  Welsh, Robert C ^a,c   Ornato, Joseph ^b   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ENOXAPARIN; EPTIFIBATIDE; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RETEPLASE; TENECTEPLASE;

ANGIOCARDIOGRAPHY; BLOOD CLOT LYSIS; CLINICAL TRIAL; DRUG EFFICACY; ELECTROCARDIOGRAM; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART INFARCTION; HEART PERFUSION; HUMAN; MEDICAL EDUCATION; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NORTH AMERICA; PATIENT CARE; PATIENT EDUCATION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; REGISTER; REVIEW; SAFETY; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0037222583     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.47     Document Type: Review

References (32)

1. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
2. Roe MT, Ohman EM, Maas AC, et al. Shifting the open-artery hypothesis downstream: The quest for optimal reperfusion. J Am Coll Cardiol 2001;37:9-18.
3. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997;337:1118-23.
4. Assessment of the Safety and Efficacy of a New Thrombolytic Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: The ASSENT-2 double-blind randomised trial. Lancet 1999;354:716-22.
5. The InTIME-II Investigators. Intravenous NPA for the treatment of infarcting myocardium early: InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J 2000;21:2005-13.
6. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001;358:605-13.
7. Topol EJ. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial. Lancet 2001;357:1905-14.
8. White H. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: The HERO-2 randomised trial. Lancet 2001;358:1855-63.
9. Barron HV, Bowlby LJ, Breen T, et al. Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2. Circulation 1998;97:1150-6.
10. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour. Lancet 1996;348:771-5.
11. Weaver WD, Cerqueira M, Hallstrom AP, et al. Pre-hospital-initiated vs hospital-initiated thrombolytic therapy: The Myocardial Infarction Triage and Intervention Trial. JAMA 1993;270:1211-6.
12. Fu Y, Goodman S, Chang WC, et al. Time to treatment influences the impact of ST-segment resolution on one-year prognosis: Insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial. Circulation 2001;104:2653-9.
13. Armstrong P, Fu Y, Goodman S, et al. The nature and outcome of patients who avoid myocardial necrosis after fibrinolysis [abstract]. Eur Heart J 2001;22(Suppl):179.
14. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-7.
15. Tiefenbrunn AJ, Chandra NC, French WJ, et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: A report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 1998;31:1240-5.
16. Blohm M, Herlitz J, Hartford M, et al. Consequences of a media campaign focusing on delay in acute myocardial infarction. Am J Cardiol 1992;69:411-3.
17. Ho MT, Eisenberg MS, Litwin PE, et al. Delay between onset of chest pain and seeking medical care: The effect of public education. Ann Emerg Med 1989;18:727-31.
18. Luepker RV, Raczynski JM, Osganian S, et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) trial. JAMA 2000;284:60-7.
19. Karagounis L, Ipsen SK, Jessop MR, et al. Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1990;66:786-91.
20. Weaver WD, Eisenberg MS, Martin JS, et al. Myocardial Infarction Triage and Intervention Project - Phase I: Patient characteristics and feasibility of pre-hospital initiation of thrombolytic therapy. J Am Coll Cardiol 1990;15:925-31.
21. Kudenchuk PJ, Ho MT, Weaver WD, et al. Accuracy of computer-interpreted electrocardiography in selecting patients for thrombolytic therapy: MITI Project Investigators. J Am Coll Cardiol 1991;17:1486-91.
22. O'Rourke MF, Cook A, Carroll G, et al. Accuracy of a portable interpretive ECG machine in diagnosis of acute evolving myocardial infarction. Aust N Z J Med 1992;22:9-13.
23. Canto JG, Rogers WJ, Bowlby LJ, et al. The prehospital electrocardiogram in acute myocardial infarction: Is its full potential being realized? National Registry of Myocardial Infarction 2 Investigators. J Am Coll Cardiol 1997;29:498-505.
24. Morrison LJ, Verbeek PR, McDonald AC, et al. Mortality and pre-hospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA 2000;283:2686-92.
25. GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. Br Med J 1992;305:548-53.
26. Report of the European Myocardial Infarction Project (EMIP) Sub-Committee. Potential time saving with pre-hospital intervention in acute myocardial infarction. Eur Heart J 1988;9:118-24.
27. Cannon CP, Sayah AJ, Walls RM. ER TIMI-19: Testing the reality of pre-hospital thrombolysis. J Emerg Med 2000;19(3 Suppl):21-5S.
28. Morrow DA, Antman EM, Sayah A, et al. Evaluation of the time saved by pre-hospital initiation of reteplase for ST-elevation myocardial infarction: Results of the early retavase-thrombolysis in myocardial infarction (ER-TIMI) 19 trial. J Am Coll Cardiol 2002;40:71-7.
29. Bonnefay E, Lapostolle F, Leizorovicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: A randomized study. Lancet 2002;360:825-9.
30. Welsh RC, Travers A, Sosnowski T, et al. Pre-hospital fibrinolysis: Is it safe, feasible, and efficient in a large urban North American Center? [abstract] J Am Coll Cardiol 2002;39(5 suppl A):279A.
31. Selker HP, Beshansky JR, Griffith JL, et al. Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia: A multicenter, controlled clinical trial. Ann Intern Med 1998;129:845-55.
32. Berger PB, Ellis SG, Holmes DR Jr, et al. Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: Results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb) trial. Circulation 1999;100:14-20.